Disclosure of Transfers of Value

Transparency is the prerequisite for building trust with the public and the patients. Therefore, from July 2017, Mylan and the legal entities Mylan IRE Healthcare Limited and Meda Health Sales Ireland Limited will disclose the monetary benefits between these entities and the players in the healthcare sector.

Methodological Note

Mylan IRE Healthcare Limited:
REP Ireland 7166 - MFE HCO Report Period 30062018
REP Ireland 7166 - MFE HCP Report Period June-30062018

Meda Health Sales Ireland Limited:
REP Ireland 9139 - MFE HCO Report Period 30062018
REP Ireland 9139 - MFE HCP Report Period 30062018